Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Results from first five years of the Europe Against Cancer Programme

28.07.2003


There are likely to have been over 92,500 fewer cancer deaths than expected in the European Union in the year 2000, according to research published today[1] (Tuesday 29 July) in Annals of Oncology – and at least part of the credit will be due to the Europe Against Cancer Programme.



Experts had calculated that EU cancer deaths would rise from just over 850,000 in 1985 to over 1.03 million in 2000 due to demographic reasons, but the new research shows that when final statistics are available, the figure is likely to be nearer to 940,500.

Although the EU’s Europe Against Cancer Programme failed to meet the ambitious target it set in the mid 1980s of cutting deaths by 15% by the year 2000, the programme does appear to have been associated with the avoidance of 92,500 deaths, said lead researcher Professor Peter Boyle, Director of the Division of Epidemiology and Biostatistics at the European Institute of Oncology in Milan, Italy.


Only Austria and Finland actually hit the 15% target for men and for women although the UK, Italy and Luxembourg came close with the UK and Luxembourg meeting the target among men. Overall in the EU there was a 10% reduction in the number of deaths expected among men and an 8% reduction among women. Portugal and Greece had the poorest performances with increases above the expected number of deaths among both men and women. The relative risk of death [the ratio of the standardised mortality rate in 2000 compared to 1985][2] fell overall in the EU by 11% in men and 10% in women.

"Although we fell short of our ambitious target the reductions are noteworthy and about half of the expected increase in cancer deaths was avoided," said Professor Boyle. "With few exceptions most countries are experiencing declining trends in cancer death rates, which seem set to continue, at least in the near future."

However, he warned against complacency. Over the five year period the number of deaths from cancer rose by 12% in men and 9% in women, which meant that the there were over 90,000 more in 2000 than in 1985. The good news was that this rise was only about half the projected increased based on demographic factors.

The report assembled all mortality data from member states in 1985 plus the three then applicant states, Sweden, Austria and Finland, which also took up the Europe Against Cancer Programme. It also looked in detail at trends among the five most common cancers – lung, stomach, colorectal, breast and prostate.

Some key findings:

Men: numbers of deaths from all forms of cancer
* 55,738 deaths avoided [estimated 526,427 deaths in 2000 instead of expected 582,165 – down 10%]
* Biggest reductions: Luxembourg (-24%), Finland (-17%), UK (-16%), Austria (-15%), The Netherlands (-14%), Italy (-13%)
* Increases: Portugal (+17%), Spain (+11%)
* Little change: Greece (+1%), Ireland (no change), Denmark (-2%).

Women: numbers of deaths from all forms of cancer
* 33,835 deaths avoided [estimated 414,083 deaths in 2000 instead of expected 450,918 – down 8%]
* Biggest reductions: Austria (-15%), Finland (-15%), Luxembourg (-13%), UK (-10%), Italy, France, Germany (-9%)
* Increases: Greece (+2%), Portugal (+3%)
* No change: Denmark, Spain

Lung cancer – men
* 23,922 deaths avoided [estimated 139,838 deaths in 2000 instead of expected 163,760 – down 15%]
* Biggest reductions: UK (-38%), Finland (-36%), The Netherlands (-29%), Luxembourg (-24%), Austria (-23%), Ireland (-22%).
* Increases: Portugal (+34%), Spain (+23%), France (+2%), Greece (+1%)
* Favourable downward trends in the risk of lung cancer death in all EU countries except France, Greece, Spain, Portugal

Lung cancer – women
* 10,613 more deaths[estimated 33,533 deaths in 2000 but actual total 44,146 – up 32%]
* Increase in each country, ranging from +8% (UK) to +84% (Netherlands)
* Risk of dying from lung cancer rose 29% overall with increases ranging up to 95% in The Netherlands
* Only country where there are indications of a near future favourable trend is the UK

Stomach cancer – men
* 22,021 deaths avoided [estimated 30,879 in 2000 instead of expected 52,900 – down 42%]
* Decline in risk of dying from stomach cancer in every member state

Stomach cancer – women
* 18,166 deaths avoided [estimated 22,169 in 2000 instead of expected 40,335 – down 45%]
* Decline in risk of dying from stomach cancer in every member state

Colorectal cancer – men
* 3,535 deaths avoided [estimated 63,672 in 2000 instead of expected 67,297 – down 5%]
* Favourable downward trends in risk in most member states
* Strongly increasing trends in risk in Spain, Portugal, Greece

Colorectal cancer – women
* 12,153 deaths avoided [estimated 61,704 in 2000 instead of expected 73,857 – down 16%]
* Favourable downward trends in risk in nearly all countries
* Upward trend in Greece, Portugal

Breast cancer
* 2,666 deaths avoided [estimated 79,608 in 2000 instead of expected 76,942 – down 3%]
* Risk of dying from breast cancer fell overall by 5%
* Biggest reductions in risk of dying were in Luxembourg (-42%), UK (-24%), Sweden (-9%)
* Biggest increases in risk of dying were in Spain (+15%), Portugal (+11%), Greece (+7%)

Prostate cancer
* 4,200 more deaths [estimated 58,800 in 2000 but actual total 60,000 – up 7%]
* Risk of dying from prostate cancer rose by 5% overall
* Risk rising in all countries except France, Italy, Luxembourg, Germany
* Trend in risk also increasing except for Austria, France, Germany, Italy, Luxembourg, UK

Commenting on the figures, Professor Boyle drew attention to the large impact that smoking made on the figures – for good in the case of men, but for ill in the case of women, and the part that tobacco contributed towards the Europe Against Cancer programme missing its 15% target.

He said: "Aside from Luxembourg where the small population makes calculations and comparisons statistically fraught, the countries that experience large declines of all forms of cancer in men also experience large declines in lung cancer. Successful tobacco control activities have made a major contribution to the declines in cancer death rates in men and the UK is a good example of this. As the risk of cancer at several sites other than the lung is associated with tobacco smoking those countries that experience declines in lung cancer also experience declines in all forms of cancer combined.

"In women the situation is, in many respects, the exact opposite. Nine out of 15 countries experienced declines of more than 10% in risk of death from all forms of cancer when lung cancer was excluded. However, the risk of dying from lung cancer in women increased substantially in every country (although it appears to be stabilising in the UK). The failure of tobacco control in women is a great disappointment. The fact that women are increasingly smoking, and smoking more, represents a great failure of public health in the recent past and is a major challenge for the near future. If women in each country had experienced the same decline in lung cancer as men, then the target may have been achieved in women and also overall.

"What this research tells us is that tobacco control must continue to be a number one priority, and women, alongside deprived populations of both sexes, must be a priority target."

He said that Finland, Austria, the UK, Luxembourg and Italy had the most effective overall programmes for reducing cancer mortality, whether directly or indirectly associated with the Europe Against Cancer programme. In contrast, cancer control seemed to be failing in Spain, Portugal and Greece and needed a boost in Denmark and Ireland.

An optimistic message was that there were strong suggestions that the risk of death from cancer is set to continue to fall in many countries into the foreseeable future, although Spain and Portugal currently posed significant cause for concern.

Professor Boyle concluded: "The reversal of a continually increasing trend has been a success that has been associated with the activities of the programme. Its major achievement has been the emphasis on prevention and the increased awareness of the importance of this aspect in wide-ranging cancer control programmes. The impact will hopefully continue to grow and continue to reduce the death rates from cancer in Europe."

Contact:

Professor David Kerr, editor-in-chief, Annals of Oncology
Tel: +44 - 1865 224482
Fax: +44 - 1865 791712
Email: david.kerr@clinpharm.ox.ac.uk

Margaret Willson | alfa
Further information:
http://www.ntrac.org.uk/restrictedArea/AnnalsOfOncology/Overview.asp

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>